|
Volumn 19, Issue 15, 2011, Pages 4513-4519
|
Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents
|
Author keywords
Antibacterial activity; Cinnamic acid; FabH inhibitors; Secnidazole
|
Indexed keywords
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (2 BROMOPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (2 CHLOROPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (2 FLUOROPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (2 METHOXYPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (2,4 DICHLOROPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (3 BROMOPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (3 FLUOROPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (3 METHOXYPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (4 BROMOPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (4 CHLOROPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (4 FLUOROPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (4 METHOXYPHENYL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (BIPHENYL 4 YL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (NAPHTHALEN 1 YL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (NAPHTHALEN 2 YL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 (THIOPHEN 2 YL)ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 4 TOLYLACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 [4 (BENZYLOXY)PHENYL]ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL 3 [4 (DIMETHYLAMINO)PHENYL]ACRYLATE;
1 (2 METHYL 5 NITRO 1H IMIDAZOL 1 YL)PROPAN 2 YL CINNAMATE;
ANTIINFECTIVE AGENT;
BETA KETOACYL ACYL CARRIER PROTEIN SYNTHASE III;
CARRIER PROTEIN;
CINNAMIC ACID SECNIDAZOLE ESTER DERIVATIVE;
KANAMYCIN;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACILLUS SUBTILIS;
BACTERIAL STRAIN;
BINDING AFFINITY;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG POTENCY;
DRUG SYNTHESIS;
ENZYME ACTIVE SITE;
ENZYME INHIBITION;
ESCHERICHIA COLI;
MINIMUM INHIBITORY CONCENTRATION;
MOLECULAR MODEL;
NONHUMAN;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS AUREUS;
STRUCTURE ACTIVITY RELATION;
3-OXOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE;
ANTI-BACTERIAL AGENTS;
BACTERIA;
BACTERIAL INFECTIONS;
CINNAMATES;
HUMANS;
INHIBITORY CONCENTRATION 50;
METRONIDAZOLE;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR DYNAMICS SIMULATION;
BACILLUS SUBTILIS;
BACTERIA (MICROORGANISMS);
ESCHERICHIA COLI;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS AUREUS;
|
EID: 79960555870
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2011.06.021 Document Type: Article |
Times cited : (21)
|
References (24)
|